Health Care/Hospital News & Press Release Distribution

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

* 1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from PN * Vitamin B Deficiency affects quality of life of ~ 19% of all Diabetics * Unveil NEW NENOIN Study results on how B Vitamins improve sensory symptoms, motor function and motor strength in PN JAKARTA, Indonesia, Nov. 6, 2...

2023-11-06 17:07 1594

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Dr.FORHAIR Announces U.S. In-Store Launch of Best Selling Hair Loss Shampoo

Global Scalp Care Brand to Launch Folligen Original Shampoo in 50 U.S. Costco Branches After Being Sold Online LOS ANGELES, Sept. 25, 2023 /PRNewswire/ -- Dr.FORHAIR, a global scalp care brand, has announced the first offline launch of its best selling Folligen Original Shampoo across 50 Costco ...

2023-11-06 16:48 748

Dr.FORHAIR Announces U.S. In-Store Launch of Best Selling Hair Loss Shampoo

Meet Joey Rabbit, the New AI-Powered 3D Virtual Mental Health Butler from Bamboo Technology

Debuts at 4th anniversary celebration of company's mental health app Here Hear, organized around World Mental Health Day 2023 TAIPEI, Nov. 6, 2023 /PRNewswire/ -- Bamboo Technology, a mental health technology innovation company, is thrilled to unveil Joey Rabbit, a state-of-the-art 3D virtual me...

2023-11-06 16:21 1306

Meet Joey Rabbit, the New AI-Powered 3D Virtual Mental Health Butler from Bamboo Technology

The Farrer Park Company Pte Ltd Appoints Ms Kelly Yang as Chief Executive Officer of Farrer Park Hospital

SINGAPORE, Nov. 6, 2023 /PRNewswire/ -- The Farrer Park Company Pte Ltd is pleased to announce the appointment of MsKelly Yang as the Chief Executive Officer (CEO) of Farrer Park Hospital (FPH). Ms Yang will succeed DrTimothy Low , the outgoing CEO, who is leaving to pursue other healthcare ventur...

2023-11-06 12:27 1573

Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D

SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the safety, pharmacokinetics (PK), and pharmacodynamics (PD) data of ASC42, a novel farnesoid X receptor (FXR) agonist, in healthy subjects ha...

2023-11-06 12:20 1482

David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep

LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer, distributor, and retailer of premium bedding products worldwide, has today announced the signing ofDavid Beckham as its newest brand ambassador.

2023-11-06 11:00 2907

David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep

LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer, distributor, and retailer of premium bedding products worldwide, has today announced the signing ofDavid Beckham as its newest brand ambassador.

2023-11-06 11:00 1513

The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval

YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug...

2023-11-06 09:11 1242

XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data

SHENZHEN, China, Nov. 6, 2023 /PRNewswire/ -- Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a mem...

2023-11-06 09:00 1783

XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data

PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association

SEOUL, South Korea, Nov. 5, 2023 /PRNewswire/ -- With much anticipation surrounding its impending release, PillWork officially announces its launch scheduled for the end of 2023. An integral part of this excitement is the company's crucial alliance with the esteemed Precision Nutrition Associatio...

2023-11-06 09:00 1196

PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association

Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-11-06 08:00 2348

Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy

SHANGHAI, Nov. 4, 2023 /PRNewswire/ -- On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clin...

2023-11-05 08:00 2225

Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

Pierre Fabre Laboratories to Acquire from Atara Biotherapeutics Commercialization Rights to EBVALLO® in the United States, Canada and All Remaining Markets Pierre Fabre Laboratories to Take Over All Manufacturing, Clinical, and Regulatory Activities for EBVALLO® Following Transition Period This...

2023-11-04 00:52 1730

Verismo Therapeutics Announces Upcoming Presentation at SITC 2023

PHILADELPHIA, Nov. 3, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy of Cancer 38th Annual Meeting (SITC 2023), to be held in San Diego and ...

2023-11-03 21:00 1760

FEBICO Makes Strides at Vitafoods Asia, Showcasing Ambitions in Asia

TAIPEI, Nov. 3, 2023 /PRNewswire/ -- Far East Bio-Tec Co., Ltd. made significant headway at this year's Vitafoods Asia exhibition held inBangkok in September. The company, under its FEBICO brand, is taking proactive steps to expand into the global market, and its progress has not gone unnoticed. ...

2023-11-03 17:00 706

Screen health: New "Eye Comfort" Certification from TÜV Rheinland

TAIPEI, Nov. 3, 2023 /PRNewswire/ -- TÜV Rheinland has launched a new "Eye Comfort" star-rating certification for testing displays. For the certification, TÜV Rheinland experts test and classify displays in terms of eye comfort within a 5-star rating system. Especially for people who spend a lot ...

2023-11-03 14:26 997

Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia

SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- Mediwave, an emerging leader in healthcare technology, marked a significant milestone with the introduction of its cutting-edge end-to-end Emergency Response suite and the Smart Connected Ambulance, featuring AI and Mixed Reality technology inMalaysia. This...

2023-11-03 13:59 1099

Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia

The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan

HAIKOU, China, Nov. 3, 2023 /PRNewswire/ -- On 31st Oct., the 2nd Boao International Conference on Real World Studies of Medical Products, held in Boao,Hainan, was attended by nearly 1,000 participants from domestic and international pharmaceutical regulatory agencies, academic societies, indust...

2023-11-03 12:10 561

The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan

ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM

SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from three clinical studies of lisaft...

2023-11-03 09:15 530

ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting

SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from multiple clinical studies of the ...

2023-11-03 09:10 494